Edap Tms (EDAP) Receives News Sentiment Score of 0.16

Press coverage about Edap Tms (NASDAQ:EDAP) has been trending somewhat positive on Friday, according to Alpha One Sentiment. The research firm, a service of Accern, rates the sentiment of media coverage by reviewing more than 20 million blog and news sources in real-time. Alpha One ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Edap Tms earned a coverage optimism score of 0.16 on Alpha One’s scale. Alpha One also gave press coverage about the medical equipment provider an impact score of 0 out of 100, indicating that recent media coverage is extremely unlikely to have an impact on the company’s share price in the near term.

Here are some of the media headlines that may have effected AlphaOne Sentiment’s rankings:

Insider Buying and Selling by Quarter for Edap Tms (NASDAQ:EDAP)

Edap Tms (NASDAQ EDAP) remained flat at $3.66 on Friday. The company had a trading volume of 240,999 shares. The stock’s 50-day moving average is $2.83 and its 200-day moving average is $2.94. The stock has a market cap of $106.13 million, a P/E ratio of 23.16 and a beta of 1.02. Edap Tms has a 52 week low of $2.25 and a 52 week high of $3.85.

Edap Tms (NASDAQ:EDAP) last released its quarterly earnings results on Wednesday, May 17th. The medical equipment provider reported $0.13 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.03) by $0.16. The firm had revenue of $9.29 million during the quarter, compared to the consensus estimate of $9.35 million. Edap Tms had a net margin of 11.95% and a return on equity of 27.90%. On average, equities research analysts expect that Edap Tms will post $0.17 earnings per share for the current fiscal year.

Several research analysts recently weighed in on EDAP shares. HC Wainwright restated a “buy” rating and issued a $7.00 price objective on shares of Edap Tms in a research report on Friday, April 7th. Zacks Investment Research cut shares of Edap Tms from a “hold” rating to a “strong sell” rating in a research report on Tuesday, April 11th. Finally, ValuEngine upgraded shares of Edap Tms from a “sell” rating to a “hold” rating in a research report on Friday, May 19th.

TRADEMARK VIOLATION WARNING: “Edap Tms (EDAP) Receives News Sentiment Score of 0.16” was originally reported by sleekmoney and is the property of of sleekmoney. If you are reading this story on another site, it was copied illegally and republished in violation of U.S. & international copyright & trademark laws. The correct version of this story can be viewed at https://sleekmoney.com/edap-tms-edap-receives-news-sentiment-score-of-0-16/1916766.html.

About Edap Tms

EDAP TMS SA (EDAP) is a holding company engaged in developing and marketing the Ablatherm and Focal One devices. The Company operates two divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) (including lithotripsy activities). The Company is developing HIFU technology for the treatment of certain other types of tumors.

This story was originally published by sleekmoney (https://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://sleekmoney.com/edap-tms-edap-receives-news-sentiment-score-of-0-16/1916766.html

Receive News & Ratings for Edap Tms S.A. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms S.A. and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply

Your email address will not be published. Required fields are marked *